Envoy Medical shares fall 5.51% after-hours despite securing three new patents.

Envoy Medical, Inc. declined 5.51% in after-hours trading. The company recently secured three new patents in the U.S., Australia, and Hong Kong, which strengthen its innovation pipeline and protect next-generation cochlear implant solutions. This news is generally positive for the company, but the stock's decline suggests that investors may be reacting to other factors not mentioned in the news events.